Document Detail

The relationship between the type of bcr-abl hybrid messenger RNA and thrombopoiesis in Philadelphia-positive chronic myelogenous leukemia.
MedLine Citation:
PMID:  8374529     Owner:  NLM     Status:  MEDLINE    
Formation of the Philadelphia (Ph1) chromosome, which contains the hybrid bcr-abl gene, is thought to be the initial event in chronic myelogenous leukemia (CML). The positions of the breakpoint within the breakpoint cluster region (bcr) on the bcr-abl gene in 22 chronic-phase cases of Ph1-positive CML were determined using conventional Southern blots, and the splicing pattern were also determined the species of the fused bcr-abl mRNA in 79 CML cases using the polymerase chain-reaction procedure (RT-PCR). The location of the breakpoint within the bcr locus was assigned to one of five zones. Breakpoints in zones 1 and 2 were grouped as 5', and those in zones 3, 4 and 5 as 3'. Nine patients had 5' breakpoints and 13 patients had 3' breakpoints. The platelet counts of 3' patients were significantly higher than those of 5' patients (1395 vs 274 x 10(9)/L; p < 0.03). The megakaryocyte counts from bone marrow histological sections in 3' patients (n = 12) and 5' patients (n = 7) were 63.4/mm2 and 19.5/mm2, with a significant difference at p < 0.006. The mean number of megakaryocyte progenitor cells assayed by in vitro cloning was 128.3/2 x 10(5) bone marrow cells for 3' patients (n = 7) compared with 46.3 for 5' patients (n = 4). Using the RT-PCR technique, the bcr exon 2/abl exon 2 fused mRNA (b2-a2) was detected in 18 patients, the bcr exon 3/abl exon 2 fused mRNA (b3-a2) was detected in 45 patients, and both types of mRNA were detected in 16 patients.(ABSTRACT TRUNCATED AT 250 WORDS)
K Inokuchi; T Nomura
Related Documents :
3465429 - Granulocytic sarcoma in nonleukemic patients.
8558939 - Allopurinol inhibits de novo purine synthesis in lymphoblasts of children with acute ly...
6375759 - Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis ...
1984849 - Acute nonlymphocytic leukemia with normal karyotype. is its in vivo drug susceptibility...
16103629 - Multidrug resistance as a potential prognostic indicator in acute myeloid leukemia with...
15813849 - Del (9q) aml: clinical and cytological characteristics and prognostic implications.
10563649 - Transient and falsely lateralizing flumazenil-pet asymmetries in temporal lobe epilepsy.
15794669 - Association of mild transient elevation of troponin i levels with increased mortality a...
15788009 - Zoonotic transmission of cryptococcus neoformans from a magpie to an immunocompetent pa...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  10     ISSN:  1042-8194     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  1993 May 
Date Detail:
Created Date:  1993-10-20     Completed Date:  1993-10-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  9-15     Citation Subset:  IM    
Third Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Base Sequence
Blood Platelets / physiology*
Fusion Proteins, bcr-abl / genetics*
Genes, abl*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood,  genetics*
Molecular Sequence Data
Platelet Count
RNA, Messenger / analysis*
RNA, Neoplasm / analysis
Reg. No./Substance:
0/Fusion Proteins, bcr-abl; 0/RNA, Messenger; 0/RNA, Neoplasm

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Identification of prognostic groups in follicular lymphoma. The Scotland and Newcastle Lymphoma Grou...
Next Document:  Growth factors and growth control of heterogeneous cell populations.